Target intelligence / Profile preview

Neuroprotection pathway

Molecular classification
Other
01

Overview

"Neuroprotection pathway" is not a specific molecule or receptor but refers broadly to a collection of molecular signaling cascades that promote neuronal survival and protect against cell death in the context of neurological injury or disease. These pathways include activation of pro-survival kinases such as PI3K/Akt—which can inhibit apoptosis through downstream targets like BAD and survivin—as well as modulation by nitric oxide synthase enzymes and changes in ion channel permeability. Natural products such as terpenoids have been shown experimentally to exert neuroprotective effects via these pathways. Because "neuroprotection pathway" is not a discrete molecular entity but an umbrella term for multiple interconnected biological processes and targets involved in neuronal protection, it should not be considered a canonical therapeutic target itself but rather a functional concept encompassing many potential drug targets within its network.

Other names
Neuroprotection pathwayneuroprotective pathwayneuroprotective signaling pathways
02

Mechanism of action

Activation of pro-survival kinases (e.g., PI3K/Akt), anti-apoptotic protein induction (e.g., BAD, survivin), modulation of ion channels and mitochondrial function, epigenetic regulation of gene expression related to neuronal survival

03

Biological functions

Cell survivalApoptosis inhibitionSignal transductionOxidative stress responseInflammation modulationGene regulation
04

Disease associations

Neurodegenerative diseaseIschemic injury (stroke)Other neurological disorders
05

Safety considerations

Potential off-target effects due to broad pathway involvementrisk of interfering with normal apoptotic processeschallenges in specificity for drug development targeting entire pathways rather than individual molecules
06

Interacting drugs

Gardenamide A and its derivatives (experimental)

2 more in the full profile.

07

Biomarkers

Phosphorylated Aktanti-apoptotic proteins (BAD, survivin)nitric oxide synthase activity levelssodium/calcium exchanger isoform 1 expression

Beyond the preview

Go deeper on Neuroprotection pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroprotection pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call